The MR is an important regulator of the hypothalamic-pituitary-adrenal (HPA) axis and a prime target for corticosteroids. There is increasing evidence from both clinical and preclinical studies that the MR has different effects on behavior and mood in males and females. To investigate the hypothesis that the MR sex-dependently influences the relation between childhood maltreatment and depression, we investigated three common and functional MR haplotypes (GA, CA, and CG haplotype, based on rs5522 and rs2070951) in a population-based cohort (N = 665) and an independent clinical cohort from the Netherlands Study of Depression and Anxiety (NESDA) (N = 1639). The CA haplotype sex-dependently moderated the relation between childhood maltreatment and depressive symptoms both in the population-based sample (sex × maltreatment × haplotype: ˇ = −4.07, P = 0.029) and in the clinical sample (sex × maltreatment × haplotype, ˇ = −2.40, P = 0.011). Specifically, female individuals in the population-based sample were protected (ˇ = −4.58, P = 2.0e −5 ), whereas males in the clinical sample were at increased risk (ˇ = 2.54, P = 0.0022). In line with these results, female GA haplotype carriers displayed increased vulnerability in the population-based sample (ˇ = 4.58, P = 7.5e −5 ) whereas male CG-carriers showed increased resilience in the clinical sample (ˇ = −2.71, P = 0.016). Consistently, we found a decreased lifetime MDD risk for male GA haplotype carriers following childhood maltreatment but an increased risk for male CA haplotype carriers in the clinical sample. * Corresponding author. Mineralocorticoid receptor haplotypes sex-dependently moderate depression 91
Summary
The MR is an important regulator of the hypothalamic-pituitary-adrenal (HPA) axis and a prime target for corticosteroids. There is increasing evidence from both clinical and preclinical studies that the MR has different effects on behavior and mood in males and females. To investigate the hypothesis that the MR sex-dependently influences the relation between childhood maltreatment and depression, we investigated three common and functional MR haplotypes (GA, CA, and CG haplotype, based on rs5522 and rs2070951) in a population-based cohort (N = 665) and an independent clinical cohort from the Netherlands Study of Depression and Anxiety (NESDA) (N = 1639). The CA haplotype sex-dependently moderated the relation between childhood maltreatment and depressive symptoms both in the population-based sample (sex × maltreatment × haplotype: ˇ = −4.07, P = 0.029) and in the clinical sample (sex × maltreatment × haplotype, ˇ = −2.40, P = 0.011). Specifically, female individuals in the population-based sample were protected (ˇ = −4.58, P = 2.0e −5 ), whereas males in the clinical sample were at increased risk (ˇ = 2.54, P = 0.0022). In line with these results, female GA haplotype carriers displayed increased vulnerability in the population-based sample (ˇ = 4.58, P = 7.5e −5 ) whereas male CG-carriers showed increased resilience in the clinical sample (ˇ = −2.71, P = 0.016). Consistently, we found a decreased lifetime MDD risk for male GA haplotype carriers following childhood maltreatment but an increased risk for male CA haplotype carriers in the clinical sample.
Introduction
The hypothalamic-pituitary-adrenal (HPA) axis is essential for successful adaptation to stress. However, stress exposure, especially early in life, is also a major risk factor for psychiatric disorders. Both mineralocorticoid (MR) and glucocorticoid receptors (GR) are involved in HPA-axis regulation and constitute primary targets for its end product corticosteroids (de Kloet et al., 2005) . Whereas the role of the GR has received ample attention, the MR has remained relatively unexplored. This may be due to the fact that cortisol binds with high affinity to the MR, resulting in substantial occupancy even under non-stressful circumstances (Joëls et al., 2008) . Therefore, MRs were primarily thought to facilitate GR functionality by cortisol binding (i.e., a cortisol ''chelator''). However, there is increasing evidence that the MR plays a pivotal role in HPA-axis functionality and determines susceptibility for stress-related psychiatric disorders (Ter Heegde et al., 2015; Klok et al., 2011b; Otte et al., 2010; Van Leeuwen et al., 2011; Berardelli et al., 2013) . In addition to the genomic MR, MRs located in the vicinity of the membrane and active with high hormone concentrations were recently shown to mediate rapid cortisol effects and influence stress appraisal (Karst et al., 2010) . These findings have put the MR forward as an important mediator of stress effects in the brain and point to a role for the MR in susceptibility for depression Ter Heegde et al., 2015) . The MR may be particularly important following childhood maltreatment which is a well-established risk factor for depression and associated with persistent changes in HPA-axis functionality (Heim et al., 1997 (Heim et al., , 2008 .
Several converging lines of evidence indicate that MR-mediated susceptibility for psychiatric disorders may be sex-dependent. First, a recent clinical study showed that resilience to depression associated with a functional MR haplotype was only present in females (Klok et al., 2011c) . Second, preclinical studies suggest that MR expression levels have sex-dependent consequences on fear memory (Ter Horst et al., 2012) and decision making (Ter Horst et al., 2014) . Also, chronic stress sex-dependently modulates MR expression (Karandrea et al., 2000; Kitraki et al., 2004) . Third, sex-dependent MR effects are biologically plausible in light of MR affinity for the female steroid hormone progesterone (Carey et al., 1995; Quinkler et al., 2002) , which can in turn alter MR expression (Castrén et al., 1995; Turner, 1990) . Together, these data support evidence that the role of the MR may be sex-dependent. These sex differences are important in light of consistent gender differences in the prevalence of stress-related psychiatric disorders (Cyranowski et al., 2000; Piccinelli and Wilkinson, 2000) .
Moreover, even though often overlooked, consistent sex differences exist in the endocrine stress response (Kudielka and Kirschbaum, 2005) .
This study aimed to investigate whether common and functional genetic variation in the MR would dependently moderate the relation between childhood maltreatment and depressive symptoms in a general population sample and an independent clinical sample from the Netherlands Study of Depression and Anxiety (NESDA). Haplotype analysis based on exonic sequencing of the MR gene NR3C2 in fifty Dutch individuals has shown that three common MR haplotypes exist in the 5 region based on the single nucleotide polymorphisms rs2070951 and rs5522 ( Van Leeuwen, 2010) . MR-2C/G (rs2070951) is located 2 nucleotides before the translation site of exon 2, and MRI180V (rs5522) is located within exon 2. Both SNPs affect in vitro transactivation by altering either MR expression or functionality. MRI180V substitutes isoleucine (A) for valine (G) in the N-terminal of the MR protein and in vitro testing shows that the Val-allele results in a mild loss of function compared to the Iso-allele (DeRijk et al., 2006; Van Leeuwen et al., 2011) . The MR-2C/G SNP is located outside the MR coding region but inside a Kozac translation regulatory sequence which regulates MR transcription. C-allele carriers have an increased MR expression . MRI180V and MR-2C/G are in low linkage disequilibrium (r 2 = 0.11), and the combination of these 2 SNPs results in three common MR haplotypes in the general population . These three common MR haplotypes differentially affect MR activity and are therefore appropriate to investigate the effects of functional genetic MR variation in humans (Klok et al., 2011c; Van Leeuwen et al., 2011) . Based on the known protective effects of the CA haplotype specifically in females but not in males (Klok et al., 2011c) , we hypothesized that for maltreatment-related depression, a similar protective effect would be present in females and not in males. We further hypothesized that the other MR haplotypes would have the opposite effect and would be associated with an increased vulnerability in females.
Methods

Samples
Population-based sample
Participants in the population-based sample were recruited using a website targeted at Dutch young adults and adolescents from 18 to 25 years (www.cannabisquest.nl). Details on recruitment and verification strategies have been previously published (Van Gastel et al., 2012) . Of the 1259 participants that completed comprehensive assessments and provided blood samples for genetic testing, complete data were available for 665 subjects due to a later implementation of the Childhood Trauma Questionnaire (CTQ) assessment. All participants provided a urine sample in order to verify recent self-reported cannabis use. The study was approved by the Ethical Review Board of the University Medical Center Utrecht and all participants gave written informed consent.
Clinical sample
The clinical sample consisted of data from the Netherlands Study of Depression and Anxiety (NESDA), a large ongoing cohort study on the course of depressive and anxiety disorders. A description of the study rationale, design, and methods is given elsewhere (Penninx et al., 2008) . Briefly, in 2004 Briefly, in -2007 participants aged 18 to 65 years were recruited from the community (19%), general practice (54%) and secondary mental health care (27%). A total of 2981 participants were included, consisting of persons with a current or past depressive and/or anxiety disorder and healthy controls. Psychiatric diagnoses according to DSM-IV criteria were established with the lifetime version of the Composite International Diagnostic Interview (CIDI 2.1). The research protocol was approved by the Ethical Review Board of participating universities and all respondents provided written informed consent. Analyses were performed on the total sample for which genetic data were available (N = 1639) with depressive symptoms (IDS) as outcome in order to directly compare the population-based sample with the clinical sample (Table 1) . Moreover, to investigate whether the risk for MDD would be increased over a longer time period, lifetime MDD diagnosis was also used as outcome.
Measures
Childhood maltreatment
Childhood maltreatment was assessed using the 25-item version of the Childhood Trauma Questionnaire (CTQ) in the population-based sample (Bernstein and Fink, 1998) . The CTQ assesses five types of self-report childhood trauma: emotional, physical, and sexual abuse, and emotional and physical neglect. The validity of the CTQ, including a Dutch translation, has been demonstrated in clinical and community samples (Bernstein and Fink, 1998; Thombs et al., 2009) . One translated item (''I believe I was molested'') was excluded in the discovery sample as this translation was found to be an invalid indicator of childhood sexual abuse in a previous validation study ( Thombs et al., 2009) . In the population-based sample, childhood maltreatment was used as the continuous sum score divided by the number of completed items. In the clinical NESDA sample, childhood trauma was assessed using a semi-structured childhood trauma interview also used in the Netherlands Mental Health Survey and Incidence Study (NEMESIS) (for details, see (De Graaf et al., 2002) ). Participants were asked whether they had experienced any kind of emotional neglect, psychological, physical or sexual abuse before the age of 16. Subsequently, a self-constructed childhood trauma index (sum scores of frequency ranging from 0 to 8) was calculated with a higher score indicating more types and a higher frequency of childhood trauma (Hovens et al., 2012) . These scores were subsequently categorized into five categories: 0 = 0, 1 = 1-2, 2 = 3-4, 3 = 5-6, and 4 = 7-8.
Depressive symptoms and MDD
In the population-based sample, depressive symptoms were assessed with the Beck Depression Inventory (BDI). This validated 21-item self-report questionnaire measures current depressive symptoms during the last week with a total score ranging from 0 to 63. In order to allow the comparison to the population-based sample, depressive symptoms over the past week were used as outcome in the clinical sample as assessed with the self-report 30-item Inventory of Depressive Symptomatology (IDS-SR30) (Rush et al., 1996) . Moreover, the presence of a lifetime MDD diagnosis (assessed using the CIDI which was conducted by trained clinical research staff) was also used as outcome to examine whether the MR was associated with maltreatment-related MDD across the life span.
Mineralocorticoid receptor haplotypes and diplotypes
MR haplotypes were calculated based on the 2G/C (rs2070951) and I180V (rs5522) SNPs in the MR promoter region. These haplotypes display differential activity at the transcriptional, translational and transactivational level (Klok et al., 2011b; Van Leeuwen et al., 2011) . In the population-based sample, SNP data were extracted as previously described (Vinkers et al., 2013) . In short, genotype data were generated on three different array platforms: the IlluminaHumanOmniExpress (N = 576), the IlluminaHuman610-QuadBeadchip (N = 768), and the IlluminaHumanHap550 array (N = 34) and extensive quality control was subsequently carried out. All participants were of Dutch ancestry. From these data, the 2G/C (rs2070951) and I180V (rs5522) SNPs were extracted. In the clinical sample, genotyping was performed on multiple chip platforms in partially overlapping different subsets of the total sample (Affymetrix-Perlegen 5.0 and Affymetrix 6.0) and data were imputed using the 1000 Genomes phase 1 Integrated Release Version 3 All panel. All post-imputation QC criteria were met; r2hat values were 0.87 for rs2070951 and 0.88 for rs5522. SNP allele frequencies were tested for deviations from the Hardy-Weinberg Equilibrium. To investigate the contribution of specific combinations of haplotypes, diplotypes (the specific combination of haplotypes) were calculated for each individual.
Covariates
Sex and age were used as covariates in all analysis. Cannabis use was included as covariate in analyses in the population-based sample as this cohort was originally set up to investigate the effects of cannabis on mental health. Current cannabis use was defined as use more than an equivalent of 3 euros per week (roughly equivalent to weekly cannabis use) during the last month or longer (Schubart et al., 2011) . Exclusion of cannabis use in the analyses did not change any of the results. 
Statistical analysis
To examine the interaction between MR haplotypes, sex, and childhood maltreatment on depressive symptoms, the total depression score was regressed on childhood maltreatment, MR haplotype, their interaction, and covariates using the following model: Depressive symp-
maltreatment × sex). Also, logistic regression analyses were also carried out in the clinical sample with lifetime MDD diagnosis as outcome. Preplanned separate analyses of male and female individuals were carried out to investigate the directionality of the MR effects between sexes. Additionally, to investigate how sex-dependency would influence the interaction between the MR haplotypes and childhood maltreatment, we carried out test of models fit with and without sex as a factor with a likelihood ratio test.
Included covariates were age (in both samples) and cannabis use (in the population-based sample only, modeled as a dichotomous indicator). MR haplotypes were coded 0, 1, or 2 and modeled as a linear effect (additive genetic model) to account for different genotype distributions. MR diplotypes (the combination of 2 haplotypes per individual) were constructed by combinations of the three haplotypes and analyzed relative to the largest diplotype group (GA-CA) using dummy coding. Continuous sum scores of childhood maltreatment were used in both samples. Causal inference of sex-dependent GA haplotype effects was analyzed using the mediation package (Tingley et al., 2014) with haplotypes collapsed to two equal groups with 1000 permutations. All analyses were performed in R (www.r-project.org). As haplotype inference is based on previous functional studies of the MR and these haplotypes are not independent, we refrained from multiple testing correction.
Results
Sample characteristics
Characteristics of the population-based and clinical sample are summarized in Table 1 . On average, participants in the clinical sample were older compared to the populationbased sample (P < 0.001). SNP allele frequencies did not deviate from Hardy-Weinberg Equilibrium in both samples (all P-values >0.10, Table 2 ) and are in line with published data (Klok et al., 2011c; Van Leeuwen et al., 2011) . Three MR haplotypes were found in both samples which is comparable to the published literature (Klok et al., 2011c; Van Leeuwen et al., 2011) (Table 1) . Six different combinations of haplotype (diplotypes) were present with comparable frequencies across samples with the GA-CA diplotype being the most prevalent (population-based sample: 37%; clinical sample: 55%), followed by the GA-GA diplotype (populationbased sample: 29%; clinical sample: 18%) (Supplementary Table S1 ). Table 2 shows the results of the linear regression model in the population-based sample for the three MR haplotypes. The association between childhood maltreatment, MR haplotype, and depressive symptoms (BDI score) was sex-dependent for the GA haplotype (sex × maltreatment × haplotype ˇ = 3.73, P = 0.040, Table 2 The relation between MR haplotypes, sex, and childhood maltreatment on depressive symptoms in the population-based sample (N = 665) for the GA haplotype (A), the CA haplotype (B), and the CG haplotype (C).
Sex-dependence of MR haplotypes on depressive symptoms in the population-based sample
(A) MR GA (1) 1A ) and CA haplotype (sex × maltreatment × haplotypě = −4.07, P = 0.029), but not for the relatively infrequent CG haplotype (sex × maltreatment × haplotype, ˇ = 2.96, P = 0.41). Childhood maltreatment was significantly associated with depressive symptoms in all analyses (P < 0.01). Exclusion of cannabis use in the model did not change any of the results. Analysis of the separate SNPs showed that the three-way interaction between sex, maltreatment and the separate SNPs was significant for rs2070951 (sex × maltreatment × rs2070951 interaction, P = 0.040) but not rs5522 (sex × maltreatment × rs5522 interaction, P = 0.41).
Subsequently, we analyzed male and female individuals separately. For females, the GA haplotype was associated with increased depressive symptoms after childhood maltreatment in females (ˇ = 4.58, P = 7.5e −5 ), whereas female CA haplotype carriers were protected (ˇ = −4.58, P = 2.0e −5 ). In contrast, no significant main effect was found in male individuals for the GA haplotype (haplotype: = −2.17, P = 0.26; maltreatment × haplotype interaction: = 1.03, P = 0.45) or the CA haplotype (haplotype: ˇ = 1.91, P = 0.36; maltreatment × haplotype interaction: ˇ = 1.47, P = 0.62). For the CG haplotype, separate analysis of male and female individuals did not show significant effects of haplotype regardless of maltreatment (all P-values >0.36). Significant effects of childhood maltreatment were found in all analyses (all P-values <0.002). Mediation analysis showed that gender did not causally influence CA haplotype modification of childhood maltreatment (mediated proportion <1%, P > 0.9). 
MR CA haplotype: 2 copies
Childhood Maltreatment (total score) CTI score Fig. 1 The interaction between sex, the MR CA haplotype and childhood maltreatment on depressive symptoms in the populationbased sample (A, BDI score, P = 0.029) and in the clinical sample (B, IDS score, P = 0.010).
Sex-dependence of MR haplotypes on depressive symptoms in the clinical sample
In the clinical sample, there was a significant sex-dependent association in the relation between childhood maltreatment and depressive symptoms (IDS score) for the CA haplotype (sex × maltreatment × haplotype, ˇ = −2.41, P = 0.010) and the CG haplotype (sex × maltreatment × haplotype, = 3.00, P = 0.020) but not for the GA haplotype (sex × maltreatment × haplotype, ˇ = 0.90, P = 0.34) (Table 3, Fig. 1B) . Childhood maltreatment was significantly associated with depressive symptoms in all analyses (P < 0.05). Analysis of the separate SNPs showed that the three-way interaction between sex, maltreatment and the separate SNPs was not significant for rs2070951 (sex × maltreatment × rs2070951 interaction, P = 0.34) but was significant for rs5522 (sex × maltreatment × rs5522 interaction, P = 0.020).
Subsequently, male and female individuals were analyzed separately. Childhood maltreatment was associated with increased depressive symptoms for male CA haplotype carriers (ˇ = 2.54, P = 0.0022), whereas male CG haplotype carriers were protected (ˇ = −2.71, P = 0.016). In contrast, no significant effects were found in female individuals for the CA haplotype (haplotype: ˇ = −1.01, P = 0.21; maltreatment × haplotype interaction: ˇ = 0.14, P = 0.78) or Table 3 The relation between MR haplotypes, sex, and childhood maltreatment on depressive symptoms (IDS score) in the clinical sample (N = 1639) for the GA haplotype (A), the MR CA haplotype (B), and the CG haplotype (C).
(A) MR GA (1) the CG haplotype (haplotype: ˇ = 0.36, P = 0.75; maltreatment × haplotype interaction: ˇ = 0.29, P = 0.69). For the GA haplotype, separate analysis of males and females did not show significant effects of haplotype regardless of maltreatment (all P-values >0.17). For all haplotypes, significant effects of childhood maltreatment were found (P < 0.001). Mediation analysis showed that gender did not causally influence CA haplotype modification of childhood maltreatment (mediated proportion <1%, P > 0.9).
Inclusion of antidepressant use as covariate did not change any of the results rather than enhancing the sexdependent effects of the CA haplotype (ˇ = −2.36, P = 0.008) and the CG haplotype (ˇ = 3.00, P = 0.004).
Sex-dependence of MR haplotypes on lifetime MDD in the clinical sample
With lifetime MDD as outcome, sex differences with regard to the association between maltreatment and MDD nearly reached statistical significance for the CA haplotype (sex × maltreatment × haplotype interactioň = −0.49, P = 0.06) and an overall CA haplotype effect for maltreatment-related MDD (maltreatment × haplotype interaction, ˇ = 0.62, P = 0.005). For the CG haplotype, sex differences were also observed (sex × haplotype interaction ˇ = −0.68, P = 0.04) even though this effect appeared to be independent of maltreatment (sex × maltreatment × haplotype interaction ˇ = 0.36, P = 0.29). For the GA haplotype, no significant sex differences were observed, even though this haplotype was significantly associated with maltreatment-related lifetime MDD (maltreatment × haplotype interaction, = −0.44, P = 0.025). Analysis of the separate SNPs showed no significant 3-way interaction for rs2070951 (sex × maltreatment × rs2070951, P = 0.27), even though there were significant maltreatment-related effects of rs2070951 (maltreatment × rs2070951 interaction, P = 0.025). Moreover, no significant 3-way interaction was found for rs5522 (sex × maltreatment × rs5522, P = 0.29), even though sex-dependent effects independent of maltreatment were present (sex × rs5522 interaction, P = 0.044).
Subsequently, we analyzed male and female individuals separately. Childhood maltreatment was associated with decreased MDD risk for male GA haplotype carriers (ˇ = −0.44, P = 0.025), whereas male CA haplotype carriers were more vulnerable following maltreatment (ˇ = −0.62, P = 0.005). For the CG haplotype, no significant effects of haplotype were found in males regardless of maltreatment.
In contrast, no significant effects were found in female individuals for the GA haplotype (haplotype: ˇ = 0.25, P = 0.07; maltreatment × haplotype interaction: ˇ = −0.17, P = 0.23), the CA haplotype (haplotype: ˇ = −0.20, P = 0.17; maltreatment × haplotype interaction: ˇ = 0.12, P = 0.40), or the CG haplotype (haplotype: ˇ = −0.17, P = 0.40; maltreatment × haplotype interaction: ˇ = 0.13, P = 0.56).
In all analyses, significant effects of childhood maltreatment were found (P < 0.001). For all analyses, inclusion of current antidepressant use as covariate did not change any of the results.
Main analysis and two-way interactions for the CA haplotype in both samples
The CA haplotype most unambiguously presents the interaction in the two samples. To enhance the interpretation of the three-way interactions, we have also reported the main and 2-way interactions for the CA haplotype. This CA haplotype shows significant two-way interactions with childhood maltreatment in the population-based and clinical sample. In Supplemental Tables S2-S4, detailed models on the main effects and the 2-way interactions for both the population-based (depressive symptoms) and the clinical sample (depressive symptoms and lifetime MDD) are presented. Moreover, figures displaying the means for the 3-way interaction of the CA, GA and CG haplotype have been included in the Supplementary material, with childhood maltreatment as a dichotomous outcome (rather than a continuous indicator as used in the main analyses) to enhance the interpretation of our data ( Supplementary Figs.  S1-S5 ).
MR diplotype analyses in both samples
In addition to the effect of MR haplotypes, the contribution of MR diplotypes (specific combinations of haplotypes) was also studied in both samples using depressive symptoms as outcome. Compared to the most common GA/CA diplotype, consistent sex-dependent effects were found for the GA/GA diplotype in the population-based sample (sex × maltreatment × diplotype interaction ˇ = 13.39, P < 0.001, sex × diplotype interaction ˇ = −15.54, P < 0.001) and the clinical sample (sex × maltreatment × diplotype interaction ˇ = 4.91, P = 0.004) (see Supplementary Table S5 ). In the clinical sample, the CG/CG (sex × maltreatment × diplotype interaction ˇ = 11.02, P = 0.011) and CG/CA diplotype (sex × maltreatment × diplotype interaction ˇ = 3.98, P = 0.041) significantly moderated the relation between maltreatment and depressive symptoms, consistent with the significant sex-dependent effects of the CG haplotype in this sample (see Section 3.3). The results of the CG/CG diplotype should be cautiously interpreted since only a few individuals possess the diplotype (Supplementary Table S1 ).
Likelihood ratio test with sex as additional factor
In the population-based sample, models with sex had a superior fit over models without sex for the GA and CA, but not the CG haplotype (GA haplotype: F(657, 4) = 4.11, P = 0.0027, CA haplotype: F(657, 4) = 2.74, P = 0.028, CG haplotype: F(657, 4) = 1.14, P = 0.34). For the clinical sample, models with sex had a superior fit only for the GA haplotype (GA haplotype: F(1280, 4) = 2.37, P = 0.050, CA haplotype: F(1280, 4) = 1.38, P = 0.24, CG haplotype: F(1280, 4) = 0.877, P = 0.48).
Discussion
The present study shows that the interaction between childhood maltreatment and functional MR haplotypes in determining depression susceptibility is sex-dependent. These data therefore indicate that sex is an important factor in determining whether functional MR haplotypes are beneficial or detrimental. Across samples, the CA haplotype seems to present either females with an advantage (the discovery sample) or males at a disadvantage (the replication sample), whereas the opposite is apparent for the GA and CG haplotype (Tables 2 and 3 ).
Focus on MR
This study focused on the potential role of the MR since this receptor has emerged as an important moderator of stress, regardless of sex (Rozeboom et al., 2007) . Preclinical data suggest that increased MR expression in the limbic system may translate to a more favorable strategy to appraise and respond to a novel and potentially stressful situation (Ter Horst et al., 2012) . In rodents, antidepressants induce hippocampal MR activity (Bjartmar et al., 2000; Seckl and Fink, 1992) . Moreover, in humans, the response to antidepressants for MDD was found to be accelerated by the MR agonist fludrocortisone (Otte et al., 2010) . The mechanisms underlying these MR actions remain to be established. The high cortisol affinity of MR contributes to the fact that in the brainwhere other binding proteins including cortisol-binding globulins are absent -cortisol levels remain relatively low under basal conditions and do not ''overshoot'' under stressful circumstances. This may in part explain why deletion of the MR in rodents results in decreased neuronal viability in the limbic system. However, the MR also exerts rapid effects on neurotransmission and synaptic plasticity in the amygdala and hippocampus under stressful circumstances (Karst et al., 2010 (Karst et al., , 2005 . Overall, the MR exerts slow genomic actions on the one hand, determining -among other things -the threshold of the stress response and neuronal viability. On the other hand, there are rapid non-genomic actions of the MR which are thought to influence the appraisal of an acute stressful situation Ter Heegde et al., 2015; Reul et al., 2000) .
MR genetic variation causes sex-dependent effects
The sex-dependent results should be interpreted in light of the different functionality of the haplotypes. First, the GA haplotype shows a significant lower maximal transactivation and a lower protein expression compared to the CA and CG haplotypes. Tests of the promoter region of the three haplotypes in vitro revealed different activities under basal non-stimulated conditions, with the GA haplotype having the highest activity and the CG haplotype the lowest (Klok et al., 2011b) . Therefore, loss of function, differential translational activity and promoter activity all contribute to the variability of in vivo MR-expression and activity with regard to these two exon SNPs. It is currently unknown how sex differences relate to these functional differences. However, the female steroid hormone progesterone binds to the MR, and both estrogen and progesterone can influence MR expression levels (Carey et al., 1995; Quinkler et al., 2002) . Thus, estrogen has been found to decrease hippocampal MR transcription in female rats, using a solution-hybridization RNase protection assay (Burgess and Handa, 1993) . This estrogen-induced decrease in MR transcription was confirmed for all hippocampal subfields with in situ hybridization and found to result in decreased MR binding capacity (Carey et al., 1995) . Therefore, the MR CA haplotype -which is associated with increased MR expression and activity -may provide at least partial compensatory enhancement of the MR function in females and this compensatory action is expected to be particularly effective in females. Interestingly, (neonatal) androgen treatment caused an upregulation of hippocampal MR expression in male rats (Karimi et al., 2013) . In analogy to the situation proposed above for female rats, the relatively low MR expression associated with the GA haplotype may compensate for this androgen-induced MR upregulation particularly in male individuals. Sex-dependent effects related to the HPA-axis in connection with genetic variations in MR are not unprecedented. For instance, dexamethasone suppression of the CAR was highest in female carriers of the GA haplotype whereas male GA haplotype carriers showed an attenuated suppression . Also, female but not male homozygotic C-carriers of rs2070951 (present in the CA and CG haplotype) had an attenuated increase of the cortisol awakening response (Klok et al., 2011c) . Sex differences have also been reported for MR mRNA levels in the human hippocampus, with higher concentrations in women compared to men (Watzka et al., 2000) . Despite the increasing evidence for sex differences in MR functionality and expression in humans, the molecular background of these differences appears to be diverse and is not yet fully understood.
Relevance for psychopathology
Even though robust sex differences exist in depression incidence (Cyranowski et al., 2000; Piccinelli and Wilkinson, 2000) and HPA-axis activity (Kirschbaum et al., 1999; Kudielka and Kirschbaum, 2005) , the role in geneenvironment studies has received relatively little attention in the literature. This study adds to the paucity of data by showing that MR haplotypes sex-dependently influence the association between childhood maltreatment and depressive symptoms in two independent samples. However, it is important to note that the MR alone cannot explain the large sex differences in depression, notwithstanding the fact that a female vulnerability was found in the most prevalent haplotype. Rather, genetic variation in the MR can only contribute to our knowledge together with other genes, and sex differences are likely to be polygenic. From a broader perspective, our results fit earlier twin studies that have found evidence for sex differences in the genetic risk for depression (Kendler et al., 2001 (Kendler et al., , 2006 . Moreover, our finding that the effects of MR haplotypes on depression seem to emerge after exposure to childhood maltreatment supports and extends the recent finding that the MR CA haplotype is associated with reduced chances on depression and enhanced optimism in females but not in males (Klok et al., 2011b) . Furthermore, these maltreatment-induced MR effects are consistent with the observation that early adversity has a large effect on HPA axis activity (Heim and Nemeroff, 2001) .
Sex-dependent MR effects of maltreatment-related depressive symptoms are supported by three converging lines of evidence. First, sex-dependent effects are plausible from a biological perspective as the female steroid hormones estrogen and progesterone both display MR affinity and can affect HPA axis activity (Carey et al., 1995; Quinkler et al., 2002) . Moreover, progesterone and estrogen can affect MR expression (Castrén et al., 1995; Turner, 1990) . Moreover, the estrogen receptor was found to inhibit transactivational MR activity across cell types (Barrett Mueller et al., 2014) . Sex-specific effects may be particularly visible during specific phases of the menstrual cycle, since both MR-deficient and stressed female mice show an improved performance in the estrus phase (Ter Horst et al., 2012) .
Second, preclinical studies suggest that the regulation of MR expression and the subsequent behavioral and molecular consequences are gender-dependent. In a fear-conditioned memory test, female but not male MR-deficient mice were unable to extinguish fear memory (Ter Horst et al., 2012) . Furthermore, after 14 days of restraint stress, female rats showed an upregulation of hippocampal MR (but unaltered GR) whereas male rats displayed limited MR downregulation (but downregulated GR) (Karandrea et al., 2000) . Moreover, hippocampal MR expression in the CA3 was specifically increased in female rats accompanied by an enhanced memory performance (Kitraki et al., 2004) . In contrast, 15 days of chronic unpredictable stress in young rats sex-dependently affected MR expression in a opposite manner, with female rats having a downregulated MR but male rats an upregulated MR (Llorente et al., 2011) . This discrepancy could be explained by the difference in the stress protocol and the age at which it was applied Rats were sacrificed 47 days after stress in the first study (Llorente et al., 2011) , but directly after the stressor in the other two studies (Karandrea et al., 2000; Kitraki et al., 2004) . Despite this discrepancy, the studies share the finding that sex-specific MR effects emerge after chronic stress exposure.
Finally, even though the number of clinical studies examining sex effects are limited, resilience to depression was previously associated with the MR CA haplotype in females only (Klok et al., 2011b) . Research into sex-dependent effects of the GA and CG haplotype are scarce. However, sex-dependent effect of the GA haplotype on dexamethasone suppression have been found with an enhanced suppression of the cortisol awakening response in female carriers . Together, these studies underscore that the MR may play an important role in determining sex differences in stress reactivity and subsequent susceptibility to develop depression, and support a particular role for the MR after exposure to chronic or traumatic stress.
Even though the sex-by-genotype interactions were generally consistent between the population and clinical sample, the effects of the CA haplotype appear to be the result of increased resilience in females in the population sample, whereas male CA haplotype carriers display an increased vulnerability for depression in the clinical sample. Moreover, there was no significant sex-dependent effect of the GA haplotype in the clinical sample for depressive symptoms, even though a significant effect was found using lifetime MDD as outcome (Table 4) . Nevertheless, even though the diplotype results should be cautiously interpreted in light of the limited power, the GA/GA diplotype resulted in sex-dependent susceptibility for depressive symptoms after childhood maltreatment in both samples. Also, no sex-dependent effect of the CG haplotype was observed in the population-based sample. There may be several reasons for the observed differences between these samples. First, the majority of the clinical sample was clinically depressed. This may be directly related to MR functionality and explain some of the differences to the healthy population sample. Indeed, post-mortem studies of MDD patients have pointed to a consistently decreased MR mRNA expression (Klok et al., 2011a; Lopez et al., 1998; Medina et al., 2013) . Moreover, antidepressant use may have influenced the results. Antidepressants affect hippocampal MR activity in preclinical studies (Bjartmar et al., 2000; Seckl and Fink, 1992) , and the effects of SSRIs on cortisol regulation have been shown to depend on the MR genotype (Klok et al., 2011c) . Inclusion of antidepressant use as a covariate did not change any of the results. However, our data are not suitable to distinguish the effects of depression from medication use. Second, the higher average age in the clinical sample may also have influenced our results. Older individuals display a blunted response to acute pharmacological interventions targeted at HPA axis functionality, either with the MR agonist fludrocortisone (Otte et al., 2003) or the MR antagonist canrenoate (Giordano et al., 2005) . Third, the population-based sample may have possessed insufficient power to detect sex-dependent effects of the relatively rare CG haplotype (∼9%).
Study design
The results of the present study should be interpreted in the context of several potential limitations. First, since the data are cross-sectional, our results cannot provide information about the causality of the relationship between childhood trauma and depression. Second, childhood trauma was retrospectively assessed and may be subject to recall bias depending on personal characteristics (Monroe, 2008) .
However, CTQ scores are stable over time and have good convergent and divergent validity (Bernstein and Fink, 1998; Bernstein et al., 1994) , and childhood trauma in the clinical sample was ascertained with a different scale using a semi-structured interview. Third, depression may negatively influence reporting of early life stress. Nevertheless, results were comparable between the population-based and clinical sample, suggesting that a mood-congruent recall bias cannot completely explain our results.
The present study also has several strengths. First, the sex-dependent effects of the MR in the relation between childhood trauma and depressive symptoms were found in a population-based sample but also in a large and independent clinical sample containing both healthy and clinically depressed individuals. Therefore, sex-dependent MR effects on maltreatment-related depressive symptoms are apparent across samples. Second, the fact that in the clinical sample, sex-dependent effects appeared to be present with lifetime MDD as outcome confirms that a persistent effect may be present. Third, we studied functional and common genetic MR variation using one of the two known haplotype blocks in NR3C2 based on exonic sequencing . The common MR haplotypes in this paper are based on two promoter SNPs and are associated with differential expression and activity at the transcriptional, translational, and transactivational level (DeRijk et al., 2006; Klok et al., 2011b; Van Leeuwen et al., 2011) . MR-2G/C (rs2070951) is located 2 nucleotides before the translation site of exon 2, while MRI180V (rs5522) is located within exon 2 and results in a substitution of isoleucine for valine. Although the use of biologically informative genetic variants is a strength, it does preclude exploration of other informative genetic variation and as such increases the risk for a confirmation bias.
In conclusion, this study shows that common and functional MR haplotypes are sex-dependently associated with depression following childhood maltreatment. These findings are relevant in light of the increased prevalence of mood disorders in women and are biologically plausible as the MR is closely involved in HPA axis functionality and stress appraisal. Together, these results provide insight into the neurobiological background of sex differences in depression risk after stress exposure and may add to the development of predictive tools for depression susceptibility.
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